184 related articles for article (PubMed ID: 24628237)
1. Antitumoral alkylphospholipids alter cell lipid metabolism.
Marco C; Ríos-Marco P; Jiménez-López JM; Segovia JL; Carrasco MP
Anticancer Agents Med Chem; 2014 May; 14(4):545-58. PubMed ID: 24628237
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.
Jiménez-López JM; Ríos-Marco P; Marco C; Segovia JL; Carrasco MP
Lipids Health Dis; 2010 Mar; 9():33. PubMed ID: 20338039
[TBL] [Abstract][Full Text] [Related]
3. Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
Carrasco MP; Jiménez-López JM; Ríos-Marco P; Segovia JL; Marco C
Br J Pharmacol; 2010 May; 160(2):355-66. PubMed ID: 20423345
[TBL] [Abstract][Full Text] [Related]
4. Alkylphospholipids: An update on molecular mechanisms and clinical relevance.
Ríos-Marco P; Marco C; Gálvez X; Jiménez-López JM; Carrasco MP
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1657-1667. PubMed ID: 28238819
[TBL] [Abstract][Full Text] [Related]
5. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.
van der Luit AH; Vink SR; Klarenbeek JB; Perrissoud D; Solary E; Verheij M; van Blitterswijk WJ
Mol Cancer Ther; 2007 Aug; 6(8):2337-45. PubMed ID: 17699729
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral alkylphospholipids induce cholesterol efflux from the plasma membrane in HepG2 cells.
Ríos-Marco P; Jiménez-López JM; Marco C; Segovia JL; Carrasco MP
J Pharmacol Exp Ther; 2011 Mar; 336(3):866-73. PubMed ID: 21148684
[TBL] [Abstract][Full Text] [Related]
7. Lipid efflux mediated by alkylphospholipids in HepG2 cells.
Ríos-Marco P; Segovia JL; Jiménez-López JM; Marco C; Carrasco MP
Cell Biochem Biophys; 2013 Jul; 66(3):737-46. PubMed ID: 23397419
[TBL] [Abstract][Full Text] [Related]
8. Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
Vink SR; van der Luit AH; Klarenbeek JB; Verheij M; van Blitterswijk WJ
Biochem Pharmacol; 2007 Nov; 74(10):1456-65. PubMed ID: 17803969
[TBL] [Abstract][Full Text] [Related]
9. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of antitumour alkylphospholipids on cholesterol transport and metabolism.
Ríos-Marco P; Marco C; Cueto FJ; Carrasco MP; Jiménez-López JM
Exp Cell Res; 2016 Jan; 340(1):81-90. PubMed ID: 26712518
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
[TBL] [Abstract][Full Text] [Related]
12. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
13. Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells.
Marco C; Jiménez-López JM; Ríos-Marco P; Segovia JL; Carrasco MP
Int J Biochem Cell Biol; 2009 Jun; 41(6):1296-303. PubMed ID: 19084611
[TBL] [Abstract][Full Text] [Related]
14. Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.
Van der Luit AH; Budde M; Zerp S; Caan W; Klarenbeek JB; Verheij M; Van Blitterswijk WJ
Biochem J; 2007 Jan; 401(2):541-9. PubMed ID: 17049047
[TBL] [Abstract][Full Text] [Related]
15. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
van Blitterswijk WJ; Verheij M
Curr Pharm Des; 2008; 14(21):2061-74. PubMed ID: 18691116
[TBL] [Abstract][Full Text] [Related]
16. Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells.
Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
Eur J Biochem; 2002 Sep; 269(18):4649-55. PubMed ID: 12230578
[TBL] [Abstract][Full Text] [Related]
17. Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells.
Nieto-Miguel T; Gajate C; Mollinedo F
J Biol Chem; 2006 May; 281(21):14833-40. PubMed ID: 16540473
[TBL] [Abstract][Full Text] [Related]
18. Alkylphospholipids deregulate cholesterol metabolism and induce cell-cycle arrest and autophagy in U-87 MG glioblastoma cells.
Ríos-Marco P; Martín-Fernández M; Soria-Bretones I; Ríos A; Carrasco MP; Marco C
Biochim Biophys Acta; 2013 Aug; 1831(8):1322-34. PubMed ID: 23707264
[TBL] [Abstract][Full Text] [Related]
19. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
[TBL] [Abstract][Full Text] [Related]
20. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast.
Cuesta-Marbán Á; Botet J; Czyz O; Cacharro LM; Gajate C; Hornillos V; Delgado J; Zhang H; Amat-Guerri F; Acuña AU; McMaster CR; Revuelta JL; Zaremberg V; Mollinedo F
J Biol Chem; 2013 Mar; 288(12):8405-8418. PubMed ID: 23335509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
